Rezultaty - Rosalie E. Ferner
- Rezultaty 1 - 20 Rezultaty od 36
- Idź do następnej strony
-
1
Neurofibromatosis 1 od Rosalie E. Ferner
Wydane 2006Revisão -
2
Neurofibromatosis-related tumors od Matthias A. Karajannis, Rosalie E. Ferner
Wydane 2014Revisão -
3
-
4
-
5
-
6
Evaluation of quality of life in adults with neurofibromatosis 1 (NF1) using the Impact of NF1 on Quality Of Life (INF1-QOL) questionnaire od Rosalie E. Ferner, Mary Thomas, Gemma Mercer, Victoria Williams, Guy Leschziner, Shazia Afridi, John F. Golding
Wydane 2017Artigo -
7
A molecular analysis of individuals with neurofibromatosis type 1 (NF1) and optic pathway gliomas (OPGs), and an assessment of genotype-phenotype correlations od S. Sharif, Meena Upadhyaya, Rosalie E. Ferner, Elisa Majounie, A Shenton, Mehmet Nuri Başer, Nalin Thakker, D. Gareth Evans
Wydane 2011Artigo -
8
[18F]2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET) as a diagnostic tool for neurofibromatosis 1 (NF1) associated malignant peripheral nerve sheath tumours (MPNS... od Rosalie E. Ferner, John F. Golding, Michael A. Smith, Eduardo Calonje, Wajanat Jan, V. Sanjayanathan, Michael O’Doherty
Wydane 2007Artigo -
9
Evaluation of 18fluorodeoxyglucose positron emission tomography (18FDG PET) in the detection of malignant peripheral nerve sheath tumours arising from within plexiform neurofibroma... od Rosalie E. Ferner, Jonathan Lucas, Michael O'Doherty, Richard Hughes, Michael A. Smith, B. F. Cronin, John Bingham
Wydane 2000Artigo -
10
-
11
Gene Expression Profiling Reveals Unique Molecular Subtypes of Neurofibromatosis Type I‐associated and Sporadic Malignant Peripheral Nerve Sheath Tumors od Mark A. Watson, Arie Perry, Tarık Tihan, Richard A. Prayson, Abhijit Guha, Julia A. Bridge, Rosalie E. Ferner, David H. Gutmann
Wydane 2004Artigo -
12
Association of sociodemographic and clinical factors with the quality of life of Brazilian individuals with Neurofibromatosis type 1: a cross-sectional study od Natália Parenti Bicudo, Carla Maria Ramos Germano, Roberta Teixeira de Moraes, Lucimar Retto da Silva de Avó, Rosalie E. Ferner, Débora Gusmão Melo
Wydane 2024Artigo -
13
High-Resolution DNA Copy Number Profiling of Malignant Peripheral Nerve Sheath Tumors Using Targeted Microarray-Based Comparative Genomic Hybridization od Kiran K. Mantripragada, Gillian Spurlock, Lan Kluwe, Nadia Chuzhanova, Rosalie E. Ferner, Ian M. Frayling, Jan P. Dumanski, Abhijit Guha, Victor Mautner, Meena Upadhyaya
Wydane 2008Artigo -
14
Guidelines for the diagnosis and management of individuals with neurofibromatosis 1 od Rosalie E. Ferner, Susan Huson, N. H. Thomas, Celia Moss, Harry Willshaw, D. Gareth Evans, Meena Upadhyaya, Richard Towers, M. Gleeson, Christoph Steiger, Amanda Kirby
Wydane 2006Revisão -
15
Functional outcome measures for NF1-associated optic pathway glioma clinical trials od Michael J. Fisher, Robert A. Avery, Jeffrey C. Allen, Simone Ardern‐Holmes, Larissa T. Bilaniuk, Rosalie E. Ferner, David H. Gutmann, Robert Listernick, Staci Martin, Nicole J. Ullrich, Grant T. Liu
Wydane 2013Artigo -
16
Bevacizumab in neurofibromatosis type 2 (NF2) related vestibular schwannomas: a nationally coordinated approach to delivery and prospective evaluation od Katrina Morris, John F. Golding, Patrick Axon, Shazia Afridi, Claire Blesing, Rosalie E. Ferner, Dorothy Halliday, R. Jena, Pieter Pretorius, D. Gareth Evans, Martin G. McCabe, Allyson Parry
Wydane 2016Artigo -
17
The characteristics of 76 atypical neurofibromas as precursors to neurofibromatosis 1 associated malignant peripheral nerve sheath tumors od Christine S. Higham, Eva Dombi, Aljosja Rogiers, Sucharita Bhaumik, Steven Pans, Steve Connor, Markku Miettinen, Raf Sciot, Roberto Tirabosco, Hilde Brems, Andrea Baldwin, Eric Legius, Brigitte C. Widemann, Rosalie E. Ferner
Wydane 2018Artigo -
18
NF1 optic pathway glioma: analyzing risk factors for visual outcome and indications to treat od Amedeo A. Azizi, David Walker, Jo‐Fen Liu, Astrid Sehested, T. Jaspan, Berthold Pemp, Ian Simmons, Rosalie E. Ferner, Jacques Grill, Darren Hargrave, Pablo Hernáiz Driever, D. Gareth Evans, Enrico Opocher
Wydane 2020Artigo -
19
Longitudinal evaluation of quality of life in 288 patients with neurofibromatosis 2 od Rosalie E. Ferner, Adam Shaw, D. Gareth Evans, Dympna McAleer, Dorothy Halliday, Allyson Parry, F. Lucy Raymond, Juliette Durie-Gair, C. Oliver Hanemann, Rachel Hornigold, Patrick Axon, John F. Golding
Wydane 2014Artigo -
20
Toxicity profile of bevacizumab in the UK Neurofibromatosis type 2 cohort od Katrina Morris, John F. Golding, Claire Blesing, D. Gareth Evans, Rosalie E. Ferner, K. Foweraker, Dorothy Halliday, R. Jena, Catherine McBain, Martin G. McCabe, Angela Swampillai, Nicola Warner, Shaun Wilson, Allyson Parry, Shazia Afridi
Wydane 2016Artigo
Narzędzie wyszukiwania:
Podobne hasła
Medicine
Neurofibromatosis
Pathology
Internal medicine
Radiology
Biology
Neurofibromatosis type 2
Cancer research
Pediatrics
Cancer
Disease
Genetics
Intensive care medicine
Magnetic resonance imaging
Neurofibromatoses
Nursing
Oncology
Quality of life (healthcare)
Surgery
Bioinformatics
Clinical psychology
Clinical trial
Environmental health
Gene
Mathematics
Neurofibroma
Population
Psychiatry
Chemotherapy
Computer science